English
简体中文
Total: £ 56.28
Published Date: 2025-12-26 | Pages: 95 | Tables: 99 | Service & Software
The global market for In Vivo Pharmacology Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
In vivo pharmacology is a critical stage in drug discovery that involves testing new drugs in living organisms to evaluate their efficacy, safety, and pharmacokinetics. In vivo studies provide valuable insights into your drug's interactions with the body, including its metabolism, absorption, distribution, and excretion. In vivo pharmacology also helps researcher identify potential side effects, determine optimal dosing regimens, and assess the drug's overall therapeutic potential.In vivo pharmacology involves studying the effects of drugs within living organisms, providing insights into their behavior, efficacy, and safety, including absorption, distribution, metabolism, and pharmacodynamics, key to the preclinical drug discovery and development process.
North American market for In Vivo Pharmacology Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for In Vivo Pharmacology Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for In Vivo Pharmacology Service in Neurological Diseases is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of In Vivo Pharmacology Service include NuChem Sciences Inc, Eurofins Discovery, Oncodesign Services, Jubilant Biosys, Pharmaron, Melior Discovery, NUVISAN GmbH, Porsolt, Sygnature Discovery, Aurigene Pharmaceutical Services Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for In Vivo Pharmacology Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vivo Pharmacology Service.
The In Vivo Pharmacology Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vivo Pharmacology Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vivo Pharmacology Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NuChem Sciences Inc
Eurofins Discovery
Oncodesign Services
Jubilant Biosys
Pharmaron
Melior Discovery
NUVISAN GmbH
Porsolt
Sygnature Discovery
Aurigene Pharmaceutical Services Ltd
Reaction Biology
Addexbio
Paraza Pharma, Inc
Aragen Life Sciences Ltd
Dalriada
Biocytogen
Charles River Laboratories
Pharmacelsu
HitGen Inc
TCG Lifesciences
Segment by Type
Small Molecule Screening
Large Molecule Screening
Others
Segment by Application
Neurological Diseases
Cardiovascular and Metabolic Diseases
Skin Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vivo Pharmacology Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vivo Pharmacology Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Small Molecule Screening
1.2.3 Large Molecule Screening
1.2.4 Others
1.3 Market by Application
1.3.1 Global In Vivo Pharmacology Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cardiovascular and Metabolic Diseases
1.3.4 Skin Diseases
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vivo Pharmacology Service Market Perspective (2020-2031)
2.2 Global In Vivo Pharmacology Service Growth Trends by Region
2.2.1 Global In Vivo Pharmacology Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In Vivo Pharmacology Service Historic Market Size by Region (2020-2025)
2.2.3 In Vivo Pharmacology Service Forecasted Market Size by Region (2026-2031)
2.3 In Vivo Pharmacology Service Market Dynamics
2.3.1 In Vivo Pharmacology Service Industry Trends
2.3.2 In Vivo Pharmacology Service Market Drivers
2.3.3 In Vivo Pharmacology Service Market Challenges
2.3.4 In Vivo Pharmacology Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vivo Pharmacology Service Players by Revenue
3.1.1 Global Top In Vivo Pharmacology Service Players by Revenue (2020-2025)
3.1.2 Global In Vivo Pharmacology Service Revenue Market Share by Players (2020-2025)
3.2 Global In Vivo Pharmacology Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In Vivo Pharmacology Service Revenue
3.4 Global In Vivo Pharmacology Service Market Concentration Ratio
3.4.1 Global In Vivo Pharmacology Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vivo Pharmacology Service Revenue in 2024
3.5 Global Key Players of In Vivo Pharmacology Service Head office and Area Served
3.6 Global Key Players of In Vivo Pharmacology Service, Product and Application
3.7 Global Key Players of In Vivo Pharmacology Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vivo Pharmacology Service Breakdown Data by Type
4.1 Global In Vivo Pharmacology Service Historic Market Size by Type (2020-2025)
4.2 Global In Vivo Pharmacology Service Forecasted Market Size by Type (2026-2031)
5 In Vivo Pharmacology Service Breakdown Data by Application
5.1 Global In Vivo Pharmacology Service Historic Market Size by Application (2020-2025)
5.2 Global In Vivo Pharmacology Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In Vivo Pharmacology Service Market Size (2020-2031)
6.2 North America In Vivo Pharmacology Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In Vivo Pharmacology Service Market Size by Country (2020-2025)
6.4 North America In Vivo Pharmacology Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vivo Pharmacology Service Market Size (2020-2031)
7.2 Europe In Vivo Pharmacology Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In Vivo Pharmacology Service Market Size by Country (2020-2025)
7.4 Europe In Vivo Pharmacology Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vivo Pharmacology Service Market Size (2020-2031)
8.2 Asia-Pacific In Vivo Pharmacology Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In Vivo Pharmacology Service Market Size by Region (2020-2025)
8.4 Asia-Pacific In Vivo Pharmacology Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vivo Pharmacology Service Market Size (2020-2031)
9.2 Latin America In Vivo Pharmacology Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In Vivo Pharmacology Service Market Size by Country (2020-2025)
9.4 Latin America In Vivo Pharmacology Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vivo Pharmacology Service Market Size (2020-2031)
10.2 Middle East & Africa In Vivo Pharmacology Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2020-2025)
10.4 Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NuChem Sciences Inc
11.1.1 NuChem Sciences Inc Company Details
11.1.2 NuChem Sciences Inc Business Overview
11.1.3 NuChem Sciences Inc In Vivo Pharmacology Service Introduction
11.1.4 NuChem Sciences Inc Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.1.5 NuChem Sciences Inc Recent Development
11.2 Eurofins Discovery
11.2.1 Eurofins Discovery Company Details
11.2.2 Eurofins Discovery Business Overview
11.2.3 Eurofins Discovery In Vivo Pharmacology Service Introduction
11.2.4 Eurofins Discovery Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.2.5 Eurofins Discovery Recent Development
11.3 Oncodesign Services
11.3.1 Oncodesign Services Company Details
11.3.2 Oncodesign Services Business Overview
11.3.3 Oncodesign Services In Vivo Pharmacology Service Introduction
11.3.4 Oncodesign Services Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.3.5 Oncodesign Services Recent Development
11.4 Jubilant Biosys
11.4.1 Jubilant Biosys Company Details
11.4.2 Jubilant Biosys Business Overview
11.4.3 Jubilant Biosys In Vivo Pharmacology Service Introduction
11.4.4 Jubilant Biosys Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.4.5 Jubilant Biosys Recent Development
11.5 Pharmaron
11.5.1 Pharmaron Company Details
11.5.2 Pharmaron Business Overview
11.5.3 Pharmaron In Vivo Pharmacology Service Introduction
11.5.4 Pharmaron Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.5.5 Pharmaron Recent Development
11.6 Melior Discovery
11.6.1 Melior Discovery Company Details
11.6.2 Melior Discovery Business Overview
11.6.3 Melior Discovery In Vivo Pharmacology Service Introduction
11.6.4 Melior Discovery Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.6.5 Melior Discovery Recent Development
11.7 NUVISAN GmbH
11.7.1 NUVISAN GmbH Company Details
11.7.2 NUVISAN GmbH Business Overview
11.7.3 NUVISAN GmbH In Vivo Pharmacology Service Introduction
11.7.4 NUVISAN GmbH Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.7.5 NUVISAN GmbH Recent Development
11.8 Porsolt
11.8.1 Porsolt Company Details
11.8.2 Porsolt Business Overview
11.8.3 Porsolt In Vivo Pharmacology Service Introduction
11.8.4 Porsolt Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.8.5 Porsolt Recent Development
11.9 Sygnature Discovery
11.9.1 Sygnature Discovery Company Details
11.9.2 Sygnature Discovery Business Overview
11.9.3 Sygnature Discovery In Vivo Pharmacology Service Introduction
11.9.4 Sygnature Discovery Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.9.5 Sygnature Discovery Recent Development
11.10 Aurigene Pharmaceutical Services Ltd
11.10.1 Aurigene Pharmaceutical Services Ltd Company Details
11.10.2 Aurigene Pharmaceutical Services Ltd Business Overview
11.10.3 Aurigene Pharmaceutical Services Ltd In Vivo Pharmacology Service Introduction
11.10.4 Aurigene Pharmaceutical Services Ltd Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.10.5 Aurigene Pharmaceutical Services Ltd Recent Development
11.11 Reaction Biology
11.11.1 Reaction Biology Company Details
11.11.2 Reaction Biology Business Overview
11.11.3 Reaction Biology In Vivo Pharmacology Service Introduction
11.11.4 Reaction Biology Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.11.5 Reaction Biology Recent Development
11.12 Addexbio
11.12.1 Addexbio Company Details
11.12.2 Addexbio Business Overview
11.12.3 Addexbio In Vivo Pharmacology Service Introduction
11.12.4 Addexbio Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.12.5 Addexbio Recent Development
11.13 Paraza Pharma, Inc
11.13.1 Paraza Pharma, Inc Company Details
11.13.2 Paraza Pharma, Inc Business Overview
11.13.3 Paraza Pharma, Inc In Vivo Pharmacology Service Introduction
11.13.4 Paraza Pharma, Inc Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.13.5 Paraza Pharma, Inc Recent Development
11.14 Aragen Life Sciences Ltd
11.14.1 Aragen Life Sciences Ltd Company Details
11.14.2 Aragen Life Sciences Ltd Business Overview
11.14.3 Aragen Life Sciences Ltd In Vivo Pharmacology Service Introduction
11.14.4 Aragen Life Sciences Ltd Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.14.5 Aragen Life Sciences Ltd Recent Development
11.15 Dalriada
11.15.1 Dalriada Company Details
11.15.2 Dalriada Business Overview
11.15.3 Dalriada In Vivo Pharmacology Service Introduction
11.15.4 Dalriada Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.15.5 Dalriada Recent Development
11.16 Biocytogen
11.16.1 Biocytogen Company Details
11.16.2 Biocytogen Business Overview
11.16.3 Biocytogen In Vivo Pharmacology Service Introduction
11.16.4 Biocytogen Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.16.5 Biocytogen Recent Development
11.17 Charles River Laboratories
11.17.1 Charles River Laboratories Company Details
11.17.2 Charles River Laboratories Business Overview
11.17.3 Charles River Laboratories In Vivo Pharmacology Service Introduction
11.17.4 Charles River Laboratories Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.17.5 Charles River Laboratories Recent Development
11.18 Pharmacelsu
11.18.1 Pharmacelsu Company Details
11.18.2 Pharmacelsu Business Overview
11.18.3 Pharmacelsu In Vivo Pharmacology Service Introduction
11.18.4 Pharmacelsu Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.18.5 Pharmacelsu Recent Development
11.19 HitGen Inc
11.19.1 HitGen Inc Company Details
11.19.2 HitGen Inc Business Overview
11.19.3 HitGen Inc In Vivo Pharmacology Service Introduction
11.19.4 HitGen Inc Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.19.5 HitGen Inc Recent Development
11.20 TCG Lifesciences
11.20.1 TCG Lifesciences Company Details
11.20.2 TCG Lifesciences Business Overview
11.20.3 TCG Lifesciences In Vivo Pharmacology Service Introduction
11.20.4 TCG Lifesciences Revenue in In Vivo Pharmacology Service Business (2020-2025)
11.20.5 TCG Lifesciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global In Vivo Pharmacology Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Small Molecule Screening
Table 3. Key Players of Large Molecule Screening
Table 4. Key Players of Others
Table 5. Global In Vivo Pharmacology Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global In Vivo Pharmacology Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global In Vivo Pharmacology Service Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global In Vivo Pharmacology Service Market Share by Region (2020-2025)
Table 9. Global In Vivo Pharmacology Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global In Vivo Pharmacology Service Market Share by Region (2026-2031)
Table 11. In Vivo Pharmacology Service Market Trends
Table 12. In Vivo Pharmacology Service Market Drivers
Table 13. In Vivo Pharmacology Service Market Challenges
Table 14. In Vivo Pharmacology Service Market Restraints
Table 15. Global In Vivo Pharmacology Service Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global In Vivo Pharmacology Service Market Share by Players (2020-2025)
Table 17. Global Top In Vivo Pharmacology Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Pharmacology Service as of 2024)
Table 18. Ranking of Global Top In Vivo Pharmacology Service Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by In Vivo Pharmacology Service Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of In Vivo Pharmacology Service, Headquarters and Area Served
Table 21. Global Key Players of In Vivo Pharmacology Service, Product and Application
Table 22. Global Key Players of In Vivo Pharmacology Service, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global In Vivo Pharmacology Service Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global In Vivo Pharmacology Service Revenue Market Share by Type (2020-2025)
Table 26. Global In Vivo Pharmacology Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global In Vivo Pharmacology Service Revenue Market Share by Type (2026-2031)
Table 28. Global In Vivo Pharmacology Service Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global In Vivo Pharmacology Service Revenue Market Share by Application (2020-2025)
Table 30. Global In Vivo Pharmacology Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global In Vivo Pharmacology Service Revenue Market Share by Application (2026-2031)
Table 32. North America In Vivo Pharmacology Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America In Vivo Pharmacology Service Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America In Vivo Pharmacology Service Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe In Vivo Pharmacology Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe In Vivo Pharmacology Service Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe In Vivo Pharmacology Service Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific In Vivo Pharmacology Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific In Vivo Pharmacology Service Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific In Vivo Pharmacology Service Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America In Vivo Pharmacology Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America In Vivo Pharmacology Service Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America In Vivo Pharmacology Service Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa In Vivo Pharmacology Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2026-2031) & (US$ Million)
Table 47. NuChem Sciences Inc Company Details
Table 48. NuChem Sciences Inc Business Overview
Table 49. NuChem Sciences Inc In Vivo Pharmacology Service Product
Table 50. NuChem Sciences Inc Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 51. NuChem Sciences Inc Recent Development
Table 52. Eurofins Discovery Company Details
Table 53. Eurofins Discovery Business Overview
Table 54. Eurofins Discovery In Vivo Pharmacology Service Product
Table 55. Eurofins Discovery Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 56. Eurofins Discovery Recent Development
Table 57. Oncodesign Services Company Details
Table 58. Oncodesign Services Business Overview
Table 59. Oncodesign Services In Vivo Pharmacology Service Product
Table 60. Oncodesign Services Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 61. Oncodesign Services Recent Development
Table 62. Jubilant Biosys Company Details
Table 63. Jubilant Biosys Business Overview
Table 64. Jubilant Biosys In Vivo Pharmacology Service Product
Table 65. Jubilant Biosys Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 66. Jubilant Biosys Recent Development
Table 67. Pharmaron Company Details
Table 68. Pharmaron Business Overview
Table 69. Pharmaron In Vivo Pharmacology Service Product
Table 70. Pharmaron Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 71. Pharmaron Recent Development
Table 72. Melior Discovery Company Details
Table 73. Melior Discovery Business Overview
Table 74. Melior Discovery In Vivo Pharmacology Service Product
Table 75. Melior Discovery Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 76. Melior Discovery Recent Development
Table 77. NUVISAN GmbH Company Details
Table 78. NUVISAN GmbH Business Overview
Table 79. NUVISAN GmbH In Vivo Pharmacology Service Product
Table 80. NUVISAN GmbH Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 81. NUVISAN GmbH Recent Development
Table 82. Porsolt Company Details
Table 83. Porsolt Business Overview
Table 84. Porsolt In Vivo Pharmacology Service Product
Table 85. Porsolt Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 86. Porsolt Recent Development
Table 87. Sygnature Discovery Company Details
Table 88. Sygnature Discovery Business Overview
Table 89. Sygnature Discovery In Vivo Pharmacology Service Product
Table 90. Sygnature Discovery Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 91. Sygnature Discovery Recent Development
Table 92. Aurigene Pharmaceutical Services Ltd Company Details
Table 93. Aurigene Pharmaceutical Services Ltd Business Overview
Table 94. Aurigene Pharmaceutical Services Ltd In Vivo Pharmacology Service Product
Table 95. Aurigene Pharmaceutical Services Ltd Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 96. Aurigene Pharmaceutical Services Ltd Recent Development
Table 97. Reaction Biology Company Details
Table 98. Reaction Biology Business Overview
Table 99. Reaction Biology In Vivo Pharmacology Service Product
Table 100. Reaction Biology Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 101. Reaction Biology Recent Development
Table 102. Addexbio Company Details
Table 103. Addexbio Business Overview
Table 104. Addexbio In Vivo Pharmacology Service Product
Table 105. Addexbio Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 106. Addexbio Recent Development
Table 107. Paraza Pharma, Inc Company Details
Table 108. Paraza Pharma, Inc Business Overview
Table 109. Paraza Pharma, Inc In Vivo Pharmacology Service Product
Table 110. Paraza Pharma, Inc Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 111. Paraza Pharma, Inc Recent Development
Table 112. Aragen Life Sciences Ltd Company Details
Table 113. Aragen Life Sciences Ltd Business Overview
Table 114. Aragen Life Sciences Ltd In Vivo Pharmacology Service Product
Table 115. Aragen Life Sciences Ltd Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 116. Aragen Life Sciences Ltd Recent Development
Table 117. Dalriada Company Details
Table 118. Dalriada Business Overview
Table 119. Dalriada In Vivo Pharmacology Service Product
Table 120. Dalriada Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 121. Dalriada Recent Development
Table 122. Biocytogen Company Details
Table 123. Biocytogen Business Overview
Table 124. Biocytogen In Vivo Pharmacology Service Product
Table 125. Biocytogen Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 126. Biocytogen Recent Development
Table 127. Charles River Laboratories Company Details
Table 128. Charles River Laboratories Business Overview
Table 129. Charles River Laboratories In Vivo Pharmacology Service Product
Table 130. Charles River Laboratories Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 131. Charles River Laboratories Recent Development
Table 132. Pharmacelsu Company Details
Table 133. Pharmacelsu Business Overview
Table 134. Pharmacelsu In Vivo Pharmacology Service Product
Table 135. Pharmacelsu Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 136. Pharmacelsu Recent Development
Table 137. HitGen Inc Company Details
Table 138. HitGen Inc Business Overview
Table 139. HitGen Inc In Vivo Pharmacology Service Product
Table 140. HitGen Inc Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 141. HitGen Inc Recent Development
Table 142. TCG Lifesciences Company Details
Table 143. TCG Lifesciences Business Overview
Table 144. TCG Lifesciences In Vivo Pharmacology Service Product
Table 145. TCG Lifesciences Revenue in In Vivo Pharmacology Service Business (2020-2025) & (US$ Million)
Table 146. TCG Lifesciences Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report
List of Figures
Figure 1. In Vivo Pharmacology Service Picture
Figure 2. Global In Vivo Pharmacology Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global In Vivo Pharmacology Service Market Share by Type: 2024 VS 2031
Figure 4. Small Molecule Screening Features
Figure 5. Large Molecule Screening Features
Figure 6. Others Features
Figure 7. Global In Vivo Pharmacology Service Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global In Vivo Pharmacology Service Market Share by Application: 2024 VS 2031
Figure 9. Neurological Diseases Case Studies
Figure 10. Cardiovascular and Metabolic Diseases Case Studies
Figure 11. Skin Diseases Case Studies
Figure 12. Others Case Studies
Figure 13. In Vivo Pharmacology Service Report Years Considered
Figure 14. Global In Vivo Pharmacology Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global In Vivo Pharmacology Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global In Vivo Pharmacology Service Market Share by Region: 2024 VS 2031
Figure 17. Global In Vivo Pharmacology Service Market Share by Players in 2024
Figure 18. Global Top In Vivo Pharmacology Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Pharmacology Service as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by In Vivo Pharmacology Service Revenue in 2024
Figure 20. North America In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America In Vivo Pharmacology Service Market Share by Country (2020-2031)
Figure 22. United States In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe In Vivo Pharmacology Service Market Share by Country (2020-2031)
Figure 26. Germany In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific In Vivo Pharmacology Service Market Share by Region (2020-2031)
Figure 34. China In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America In Vivo Pharmacology Service Market Share by Country (2020-2031)
Figure 42. Mexico In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa In Vivo Pharmacology Service Market Share by Country (2020-2031)
Figure 46. Turkey In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE In Vivo Pharmacology Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. NuChem Sciences Inc Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 50. Eurofins Discovery Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 51. Oncodesign Services Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 52. Jubilant Biosys Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 53. Pharmaron Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 54. Melior Discovery Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 55. NUVISAN GmbH Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 56. Porsolt Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 57. Sygnature Discovery Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 58. Aurigene Pharmaceutical Services Ltd Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 59. Reaction Biology Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 60. Addexbio Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 61. Paraza Pharma, Inc Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 62. Aragen Life Sciences Ltd Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 63. Dalriada Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 64. Biocytogen Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 65. Charles River Laboratories Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 66. Pharmacelsu Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 67. HitGen Inc Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 68. TCG Lifesciences Revenue Growth Rate in In Vivo Pharmacology Service Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
